416 related articles for article (PubMed ID: 27973410)
1. Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
Zebisch A; Hatzl S; Pichler M; Wölfler A; Sill H
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973410
[TBL] [Abstract][Full Text] [Related]
2. Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia.
Liu B; Ma X; Liu Q; Xiao Y; Pan S; Jia L
Cell Death Dis; 2018 Jun; 9(6):688. PubMed ID: 29880818
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia.
Wang D; Zeng T; Lin Z; Yan L; Wang F; Tang L; Wang L; Tang D; Chen P; Yang M
Biomed Pharmacother; 2020 Mar; 123():109802. PubMed ID: 31884339
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia.
Izadirad M; Jafari L; James AR; Unfried JP; Wu ZX; Chen ZS
Drug Discov Today; 2021 Jul; 26(7):1735-1743. PubMed ID: 33781951
[TBL] [Abstract][Full Text] [Related]
5. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.
Li Q; Song W; Wang J
Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433
[TBL] [Abstract][Full Text] [Related]
6. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.
Liu Y; Cheng Z; Pang Y; Cui L; Qian T; Quan L; Zhao H; Shi J; Ke X; Fu L
J Hematol Oncol; 2019 May; 12(1):51. PubMed ID: 31126316
[TBL] [Abstract][Full Text] [Related]
8. Silencing LINC00987 ameliorates adriamycin resistance of acute myeloid leukemia via miR-4458/HMGA2 axis.
Liu Y; Zhu XY; Liao LL; Zhang ZH; Huang TS; Zhang L; Jiang XW; Ma Y
Biol Direct; 2024 Jun; 19(1):49. PubMed ID: 38910243
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemia.
Kirtonia A; Ashrafizadeh M; Zarrabi A; Hushmandi K; Zabolian A; Bejandi AK; Rani R; Pandey AK; Baligar P; Kumar V; Das BC; Garg M
J Cell Physiol; 2022 Jan; 237(1):450-465. PubMed ID: 34569616
[TBL] [Abstract][Full Text] [Related]
10. The tip of the iceberg-The roles of long noncoding RNAs in acute myeloid leukemia.
Connerty P; Lock RB
Wiley Interdiscip Rev RNA; 2023; 14(6):e1796. PubMed ID: 37267628
[TBL] [Abstract][Full Text] [Related]
11. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
[TBL] [Abstract][Full Text] [Related]
12. miRNAs in acute myeloid leukemia.
Liao Q; Wang B; Li X; Jiang G
Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNAs and endometrial cancer.
Liu H; Wan J; Chu J
Biomed Pharmacother; 2019 Nov; 119():109396. PubMed ID: 31505425
[TBL] [Abstract][Full Text] [Related]
15. Exploring the major cross-talking edges of competitive endogenous RNA networks in human Chronic and Acute Myeloid Leukemia.
Sen K; Bhattacharyya D; Sarkar A; Das J; Maji N; Basu M; Ghosh Z; Ghosh TC
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1883-1892. PubMed ID: 29902552
[TBL] [Abstract][Full Text] [Related]
16. Diverse functions of long noncoding RNAs in acute myeloid leukemia: emerging roles in pathophysiology, prognosis, and treatment resistance.
Mishra S; Liu J; Chai L; Tenen DG
Curr Opin Hematol; 2022 Jan; 29(1):34-43. PubMed ID: 34854833
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells.
Bill M; Papaioannou D; Karunasiri M; Kohlschmidt J; Pepe F; Walker CJ; Walker AE; Brannan Z; Pathmanathan A; Zhang X; Mrózek K; LaRocco A; Volinia S; Bloomfield CD; Garzon R; Dorrance AM
Leukemia; 2019 Sep; 33(9):2169-2182. PubMed ID: 30858548
[TBL] [Abstract][Full Text] [Related]
18. How do non-coding RNAs impact treatment regimens currently being used in AML?
Zebisch A; Sill H
Expert Rev Anticancer Ther; 2022 Apr; 22(4):331-333. PubMed ID: 35245428
[No Abstract] [Full Text] [Related]
19. miR signatures and the role of miRs in acute myeloid leukaemia.
Seca H; Almeida GM; Guimarães JE; Vasconcelos MH
Eur J Cancer; 2010 Jun; 46(9):1520-7. PubMed ID: 20413298
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide characterization of lncRNAs in acute myeloid leukemia.
Lei L; Xia S; Liu D; Li X; Feng J; Zhu Y; Hu J; Xia L; Guo L; Chen F; Cheng H; Chen K; Hu H; Chen X; Li F; Zhong S; Mittal N; Yang G; Qian Z; Han L; He C
Brief Bioinform; 2018 Jul; 19(4):627-635. PubMed ID: 28203711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
